Cardioprotective effect of betulinic acid on myocardial ischemia reperfusion injury in rats

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Xia, Anzhou ^a   Xue, Zhi ^a   Li, Yong ^b   Wang, Wei ^a   Xia, Jieyun ^a   Wei, Tiantian ^a   Cao, Jing ^a   Zhou, Weidong ^c  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b XUZHOU CENTRAL HOSPITAL   (China)

^c Suining County Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETULIC ACID; CREATINE KINASE; FOSINOPRIL; LACTATE DEHYDROGENASE; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARDIOVASCULAR EFFECT; COLORIMETRY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; ENZYME ACTIVITY; ENZYME RELEASE; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LOW DRUG DOSE; MALE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SHAM PROCEDURE; WESTERN BLOTTING;

EID: 84902156594     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/573745     Document Type: Article

References (27)

1. Fan J., Li G. Q., Liu J., Impact of cardiovascular disease deaths on life expectancy in chinese population. Biomedical and Environmental Sciences 2014 27 3 162 168
2. Sivaraman V., Yellon D. M., Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury. Journal of Cardiovascular Pharmacology and Therapeutics 2014 19 1 83 96
3. Jennings R. B., Sommers H. M., Smyth G. A., Flack H. A., Linn H., Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Archives of Pathology 1960 70 68 78
4. Sanada S., Komuro I., Kitakaze M., Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. American Journal of Physiology: Heart and Circulatory Physiology 2011 301 5 H1723 H1741 2-s2.0-80455143341 10.1152/ajpheart.00553.2011
5. Alakurtti S., Mäkelä T., Koskimies S., Yli-Kauhaluoma J., Pharmacological properties of the ubiquitous natural product betulin. European Journal of Pharmaceutical Sciences 2006 29 1 1 13 2-s2.0-33747802067 10.1016/j.ejps.2006.04.006
6. Ekşiolu-Demiralp E., Kardaş E. R., Özgül S., Yaci T., Bilgin H., Şehirli Ö., Ercan F., Şener G., Betulinic acid protects against ischemia/reperfusion-induced renal damage and inhibits leukocyte apoptosis. Phytotherapy Research 2010 24 3 325 332 2-s2.0-77349095057 10.1002/ptr.2929
7. Mullauer F. B., Kessler J. H., Medema J. P., Betulinic acid, a natural compound with potent anticancer effects. Anti-Cancer Drugs 2010 21 3 215 227 2-s2.0-76649106073 10.1097/CAD.0b013e3283357c62
8. Ding W., Sun M., Luo S., A 3D QSAR study of betulinic acid derivatives as anti-tumor agents using topomer CoMFA: model building studies and experimental verification. Molecules 2013 18 9 10228 10241
9. Chintharlapalli S., Papineni S., Lei P., Pathi S., Safe S., Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors. BMC Cancer 2011 11, article 371 2-s2.0-80052024865 10.1186/1471-2407-11-371
10. Viji V., Shobha B., Kavitha S. K., Ratheesh M., Kripa K., Helen A., Betulinic acid isolated from Bacopa monniera (L.) Wettst suppresses lipopolysaccharide stimulated interleukin-6 production through modulation of nuclear factor- B in peripheral blood mononuclear cells. International Immunopharmacology 2010 10 8 843 849 2-s2.0-77954958460 10.1016/j.intimp.2010. 04.013
11. Yun Y., Han S., Park E., Yim D., Lee S., Lee C.-K., Cho K., Kim K., Immunomodulatory activity of betulinic acid by producing pro-inflammatory cytokines and activation of macrophages. Archives of Pharmacal Research 2003 26 12 1087 1095 2-s2.0-4143063501
12. Lu Q., Xia N., Xu H., Guo L., Wenzel P., Daiber A., Münzel T., Förstermann U., Li H., Betulinic acid protects against cerebral ischemia-reperfusion injury in mice by reducing oxidative and nitrosative stress. Nitric Oxide 2011 24 3 132 138 2-s2.0-79954628009 10.1016/j.niox.2011. 01.007
13. Dragasis S., Bassiakou E., Iacovidou N., The role of opioid receptor agonists in ischemic preconditioning. European Journal of Pharmacology 2013 720 1-3 401 408 10.1016/j.ejphar.2013.10.001
14. Sheng Z., Yao Y., Li Y., Yan F., Huang J., Ma G., Bradykinin preconditioning improves therapeutic potential of human endothelial progenitor cells in infarcted myocardium. PloS ONE 2013 8 12 e81505
15. Yang Z., Sun W., Hu K., Adenosine A1 receptors selectively target protein kinase C isoforms to the caveolin-rich plasma membrane in cardiac myocytes. Biochimica et Biophysica Acta 2009 1793 12 1868 1875 2-s2.0-71749119732 10.1016/j.bbamcr.2009.10.007
16. Rossini R., Senni M., Musumeci G., Ferrazzi P., Gavazzi A., Prevention of left ventricular remodelling after acute myocardial infarction: an update. Recent Patents on Cardiovascular Drug Discovery 2010 5 3 196 207 2-s2.0-78650020369 10.2174/157489010793351999
17. Chen S., Liu J., Liu X., Fu Y., Zhang M., Lin Q., Zhu J., Mai L., Shan Z., Yu X., Yang M., Lin S., Panax notoginseng saponins inhibit ischemia-induced apoptosis by activating PI3K/Akt pathway in cardiomyocytes. Journal of Ethnopharmacology 2011 137 1 263 270 2-s2.0-80052033598 10.1016/j.jep.2011.05. 011
18. Zhang J., Liu A., Hou R., Zhang J., Jia X., Jiang W., Chen J., Salidroside protects cardiomyocyte against hypoxia-induced death: a HIF-1 α -activated and VEGF-mediated pathway. European Journal of Pharmacology 2009 607 1-3 6 14 2-s2.0-62149124032 10.1016/j.ejphar.2009.01.046
19. Deng C., Sun Z., Tong G., alpha-Lipoic acid reduces infarct size and preserves cardiac function in rat myocardial ischemia/reperfusion injury through activation of PI3K/Akt/Nrf2 pathway. PloS ONE 2013 8 3 e58371
20. Zhao M. M., Yang J. Y., Wang X. B., Tang C. S., Du J. B., Jin H. F., The PI3K/Akt pathway mediates the protection of SO(2) preconditioning against myocardial ischemia/reperfusion injury in rats. Acta Pharmacologica Sinica 2013 34 4 501 506
21. Gottlieb R. A., Burleson K. O., Kloner R. A., Babior B. M., Engler R. L., Reperfusion injury induces apoptosis in rabbit cardiomyocytes. The Journal of Clinical Investigation 1994 94 4 1621 1628 2-s2.0-0027967063
22. Caroppi P., Sinibaldi F., Fiorucci L., Santucci R., Apoptosis and human diseases: mitochondrion damage and lethal role of released cytochrome c as proapoptotic protein. Current Medicinal Chemistry 2009 16 31 4058 4065 2-s2.0-70450205079 10.2174/092986709789378206
23. Sun D., Huang J., Zhang Z., Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats. PloS ONE 2012 7 3 e33491
24. Wu B., Cui H., Peng X., Dietary nickel chloride induces oxidative stress, apoptosis and alters Bax/Bcl-2 and caspase-3 mRNA expression in the cecal tonsil of broilers. Food and Chemical Toxicology 2014 63 18 29
25. Verma Y. K., Raghav P. K., Raj H. G., Tripathi R. P., Gangenahalli G. U., Enhanced heterodimerization of Bax by Bcl-2 mutants improves irradiated cell survival. Apoptosis 2013 18 2 212 225
26. Xu J., Zhou M., Ouyang J., Gambogic acid induces mitochondria-dependent apoptosis by modulation of Bcl-2 and Bax in mantle cell lymphoma JeKo-1 cells. Chinese Journal of Cancer Research 2013 25 2 183 191
27. Liao Y. H., Xia N., Zhou S. F., Interleukin-17A contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration. Journal of the American College of Cardiology 2012 59 4 420 429